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Comparing External Ventricular Drains-Related Ventriculitis
Surveillance Deﬁnitions
Maria M. Reyes, MD;1 Satish Munigala, MBBS, MPH;1 Emily L. Church, MPH;4 Tobias B. Kulik, MD, PhD;2
Salah G. Keyrouz, MD, FAHA;2 Gregory J. Zipfel, MD;3 David K. Warren, MD, MPH1
objective. To evaluate the agreement between the current National Healthcare Safety Network (NHSN) deﬁnition for ventriculitis and
others found in the literature among patients with an external ventricular drain (EVD)
design. Retrospective cohort study from January 2009 to December 2014
setting. Neurology and neurosurgery intensive care unit of a large tertiary-care center
patients. Patients with an EVD were included. Patients with an infection prior to EVD placement or a permanent ventricular shunt were
excluded.
methods. We reviewed the charts of patients with positive cerebrospinal ﬂuid (CSF) cultures and/or abnormal CSF results while they had an
EVD in place and applied various ventriculitis deﬁnitions.
results. We identiﬁed 48 patients with a total of 52 cases of ventriculitis (41 CSF culture-positive cases and 11 cases based on abnormal CSF
test results) using the NHSN deﬁnition. The most common organisms causing ventriculitis were gram-positive commensals (79.2%); however,
45% showed growth of only 1 colony on 1 piece of media. Approximately 60% of the ventriculitis cases by the NHSN deﬁnition met the Honda
criteria, approximately 56% met the Gozal criteria, and 23% met Citerio’s deﬁnition. Cases deﬁned using Honda versus Gozal deﬁnitions had a
moderate agreement (κ= 0.528; P< .05) whereas comparisons of Honda versus Citerio deﬁnitions (κ= 0.338; P< .05) and Citerio versus Gozal
deﬁnitions (κ= 0.384; P< .05) had only fair agreements.
conclusions. The agreement between published ventriculostomy-associated infection (VAI) deﬁnitions in this cohort was moderate to
fair. A VAI surveillance deﬁnition that better deﬁnes contaminants is needed for more homogenous application of surveillance deﬁnitions
between institutions and better comparison of rates.
Infect Control Hosp Epidemiol 2017;38:574–579
Ventriculostomy-associated infection (VAI) is one of the most
serious complications of external ventricular drain (EVD) use.
These infections can result in increased morbidity, mortality,
prolonged hospital stay, and higher healthcare costs.1,2 The
reported incidence of VAI varies from <1% to 45%.1,3 This
wide variability in VAI incidence may be due in part to the
challenge of diagnosing VAI in the presence of an abnormal
cerebrospinal ﬂuid (CSF) proﬁle from underlying central
nervous system (CNS) disease, recent surgery,1,4 and differ-
ences among VAI deﬁnitions.1,5
The Centers for Disease Control and Prevention (CDC)
National Healthcare Safety Network (NHSN) has deﬁned
ventriculitis.6 A single positive CSF culture or non–culture-
based microbiological test meets the NSHN ventriculitis
deﬁnition. Because CSF samples for culture are generally
drawn through the EVD in the course of routine care, intra-
luminal colonization of the device may result in a positive
culture,1 thereby meeting the NHSN deﬁnition.
A recent study by Lewis et al3 compared the performances of
multiple VAI deﬁnitions. The NHSN deﬁnition was not
included in the comparison, and the antibiotic length of
therapy was used as the gold standard for ventriculitis, which
may have introduced bias due to variations in antibiotic
prescribing practices.7
NHSN surveillance data are increasingly being linked to
hospital reimbursement by regulatory agencies and payers
(eg, the Centers for Medicare and Medicaid Services). There-
fore, understanding the performance characteristics of NHSN
deﬁnitions is important. In this study, we compared VAI rates
using the NHSN deﬁnition versus other published deﬁnitions.
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methods
Study Cohort
We conducted a retrospective study of patients who under-
went placement of an EVD between January 2009 and
December 2014 and were cared for in the Barnes-Jewish
Hospital neurological and neurosurgical intensive care unit.
Inclusion and Exclusion Criteria
A total of 965 EVDs were identiﬁed during the study period.We
excluded EVDs placed in patients <18 years old and those who
had a permanent shunt, a cerebral abscess, and/or a positive
CSF culture at the time of EVD insertion. From the remaining
patients with EVDs, we included only those whose EVD and
culture status satisﬁed the NHSN deﬁnition for ventriculitis.6
These included patients having a positive CSF culture while the
EVD was in place or an abnormal CSF analysis result or positive
blood cultures in the presence of neurological symptoms. We
considered only tests that were performed while an EVD was in
place and up to 2 days after removal.
NHSN CSF Culture-Positive Episodes
We included all patients with a positive CSF culture during the
study period. If multiple organisms grew from a single CSF
culture, we considered it a polymicrobial case. If a patient had
multiple CSF cultures that grew the same organism, we
considered it a single case with the date of initial positive
culture as the case date. If a patient had multiple CSF cultures
performed and different organisms grew from >1 culture, we
considered each culture as a different case. Cultures drawn on
the same day or within 1 calendar day were part of the inclu-
sion criteria unless the patient had a pre-existing infection.
NHSN CSF Culture-Negative Cases
Patients with at least 1 CSF glucose measurement <50mg/dL
were included. Patients with all 3 additional criteria were
included for further review: CSF protein >50mg/dL, CSF
nucleated cells >5 cells/mm3, and fever >38°C.
Cerebrospinal ﬂuid analysis data (ie, protein level, density of
nucleated cells, glucose level) obtained contemporaneously
with CSF culture were considered. If no CSF analysis was
obtained when the culture specimen was obtained, we con-
sidered the CSF analysis temporally closest to the CSF culture
performed while the EVD was in place.
To assess the cases of patients who did not meet either the
positive CSF culture or the abnormal CSF criteria, we con-
ducted a chart review of all patients with a positive blood
culture(s) while the EVD was in place. If there was suspicion of
a CNS infectious source, the patient was included for further
evaluation.
Other Deﬁnitions
We applied 3 other published VAI deﬁnitions (ie, those of
Honda et al,8 Gozal et al,9 and Citerio et al10) to our cohort
(Table 1).6 All of these deﬁnitions required the growth of an
organism from a CSF culture; therefore, the patients who met
these deﬁnitions comprised a subset of the patients who met
the NHSN VAI deﬁnition by virtue of a positive CSF culture.
Data Collection
Patient demographics, CSF testing, culture results, and blood
culture data were abstracted from the hospital medical infor-
matics database. We collected the following data from the
charts: date of EVD insertion and removal (ie, extracted from
the per shift nursing assessment), EVD indication for placement,
clinical information (ie, maximal temperature, new meningeal
or cranial nerve signs within 72 hours of CSF testing), and
systemic antibiotic therapy while the EVD was in place.
We deﬁned treatment as receiving an antibiotic with activity
against the organism(s) detected in CSF cultures, based upon
susceptibilities. In the case of common commensals
with no susceptibilities reported, agents with activity against
methicillin-resistant bacteria were considered active. We
deﬁned ≥14 days as an appropriate length of antibiotic therapy
for ventriculitis. Notably, prior toMay 2012, all EVD patients in
our study received either cefazolin or vancomycin prior to
EVD placement and then as long as the catheter remained in
place. After May 2012, patients received only periprocedural
antibiotics.
Statistical Analyses
SPSS version 22 software (IBM; Armonk, NY) was used for
statistical analyses. Percentage agreements of the Honda,
Gozal, and Citerio deﬁnitions with NHSH deﬁnition were
calculated. The unweighted κ statistic was used to assess the
agreement between Honda, Gozal, and Citerio deﬁnitions.
This study was approved by the Washington University
Human Research Protection Ofﬁce.
results
After exclusions, our study cohort included 48 patients with 49
EVDs and 52 cases of ventriculitis, which included 41 culture-
positive and 11 culture-negative cases (Figure 1). The median
age of the patients was 54 years (interquartile range [IQR],
47–64 years) and 58.3% were female (n= 28). Several EVD
characteristics are listed in Table 2.
CSF Culture-Positive Cases
Overall, 37 patients with 38 EVDs contributed to 41 CSF
culture-positive cases of ventriculitis. The median time from
EVD insertion to ﬁrst positive culture was 8 days (IQR,
4–12 days). Of the 41 CSF culture-positive samples, 2 were not
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table 1. Ventriculitis Deﬁnitions Used in the Study
Name Deﬁnition Criteria Culture Criteria Gram Stain Clinical Criteria CSF Analysis Criteria Other Criteria
CDC/
NHSN6
Culture criteria alone OR 2 of 3
clinical criteria and
∙ All CSF analysis criteria OR
∙ Abnormal gram stain OR
∙ Positive blood culture
Any growth Organism present ∙ Fever >38°C
∙ Meningeal
∙ Cranial nerve signs
↑ CSF nucleated cells AND ↓ CSF
glucose AND ↑ CSF protein
…
Honda et al8 Culture alone OR if skin ﬂora,a
then at least one of CSF
analysis criteria must be met.
Any growth Should match
culture growth
∙ CSF WBC ≥10 cells/mm3 OR
∙ CSF glucose <25mg/dL OR
∙ CSF protein >50mg/dL
Consider only if at least 48 h
after EVD inserted
Gozal et al9 Culture AND clinical criteria
AND CSF analysis criteria
Any growth Fever >38.6°C ∙ CSF glucose< 50mg/dL OR
∙ CSF glucose/serum glucose
ratio≤ 50%
Includes even those in whom
criteria were met within
72 h of EVD removal
Citerio et al10 Culture criteria AND clinical
criteria AND CSF analysis
criteria
Any growth Fever > 38°C CSF WBC >5 cells/μL ANDCSF
glucose/ serum glucose ratio ≤50%
…
NOTE. CDC/NHSN, Centers for Disease Control and Prevention/National Healthcare Safety Network; CSF, cerebrospinal ﬂuid; WBC, white blood cell count; EVD, external
ventricular drain.
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sent for CSF analysis. The median number of nucleated cells in
the remaining 39 CSF samples was 60 cells/mm3 (range,
0–8,440). In total, 30 samples (76.9%) had ≥5 nucleated cells/
mm3. The median concentration of protein was 48mg/dL
(IQR, 27–87), and 19 samples (48.7%) had a protein level
>50mg/dL. The median glucose level was 74mg/dL (IQR,
66–90); only 3 samples (7.6%) had a glucose level <50mg/dL.
The microbiology of CSF cultures is shown in Table 3.
Notably, 20 of 41 culture-positive cases (49%) had an anno-
tation of “1 colony on 1 piece of media” for an organism. The
organisms growing only a single colony in culture were
coagulase-negative Staphylococcus spp (n= 11 cultures),
Micrococcus spp (n= 4), Corynebacterium spp (n= 2), Bacillus
spp, Propionibacterium spp, and unidentiﬁed yeast.
Overall, 40 positive-culture CSF (97.6%) case patients
received some antibiotic therapy, and 22 patients (53.6%)
received appropriate antibiotic for the organisms cultured. The
median length of antibiotic use was 5 days (IQR, 3–11 days).
In addition, 5 patients received treatment for ≥14 days; 4 of
these patients had gram-negative bacteria and 1 had Candida
parapsilosis. From the 20 cultures that had the annotation
“1 colony on 1 piece of media,” 7 corresponding patients (35%)
received an antibiotic with activity against the isolated
organism; none received antibiotics for >14 days.
Among the 38 EVDs in patients with ≥1 positive CSF
culture, 9 (23.6%) were removed and 3 (7.9%) were exchanged
within 48 hours of the positive culture.
CSF Culture-Negative Cases
Overall, 11 patients with 11 EVDs contributed to 11 CSF
culture-negative cases (Figure 1). The median number of
nucleated cells in these cultures was 375 cells/mm3 (IQR,
100–2,067). The median concentration of protein in patients in
this cohort was 113mg/dL (IQR, 71–332). The median glucose
level of this cohort was 45mg/dL (IQR, 27–48). All 11 case
patients received intravenous antibiotics, but none completed
14 days of therapy. Moreover, 2 EVDs (18%) were removed
within 48 hours of the abnormal CSF test results. The remaining
9 EVDs (81.8%) were neither removed nor exchanged.
ﬁgure 1. Inclusion of patients in the study. Abbreviations: EVDs, external ventricular drains; EMR, electronic medical record; CSF,
cerebrospinal ﬂuid; CNS, central nervous system, BSI, bloodstream infections; VP, ventriculoperitoneal.
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Comparison of Ventriculitis Rates
We identiﬁed 52 cases of ventriculitis using the NHSN deﬁ-
nition: 41 cases were based on a positive CSF culture, and
11 cases were based on abnormal CSF test results. Of these
cases, 31 (59.6%) met the ventriculitis criteria using the Honda
deﬁnition; 29 cases (55.8%) met the ventriculitis criteria using
the Gozal deﬁnition; and 12 cases (23.1%) met the ventriculitis
criteria using the Citerio deﬁnition. The ventriculitis rate
varied widely by deﬁnition: 6.7 cases per 1,000 EVD days using
the NHSN deﬁnition; 4.0 using the Honda criteria, 3.7 using
the Gozal criteria, and 1.5 using the Citerio criteria. No cases
were identiﬁed using the other 3 deﬁnitions but not the
NHSN deﬁnition.
Comparing the agreement among the deﬁnitions, we found
that the Honda and Gozal deﬁnitions had moderate agreement
(κ= 0.528; P< .05). The other comparisons had only fair
agreements: Honda versus Citerio (κ= 0.338; P< .05) and
Citerio versus Gozal (κ= 0.384; P< .05).
discussion
Ventriculitis rates in our study varied widely according to the
deﬁnition applied. Compared to 3 culture-based deﬁnitions in
the literature, the NSHN deﬁnition resulted in substantially
more cases of VAI being identiﬁed. This ﬁnding is most likely
due to the NHSN deﬁnition deﬁning any growth onCSF culture,
no matter the organism, the number of abnormal CSF cultures
or the degree of growth on media as infection. This deﬁnition
also classiﬁed cases as VAI based upon CSF abnormalities plus
neurological symptoms, irrespective of culture ﬁndings.
In our study, gram-positive commensals were the pre-
dominant organisms recovered from CSF cultures (79.3%).
These organisms are the most commonly implicated as a
cause of VAI,5,1 but they also frequently cause culture con-
tamination or catheter colonization. We found that 45%
of the common commensals had an annotation by the
laboratory of “1 colony on 1 piece of media,” which calls into
question their signiﬁcance as a pathogen. Of the other VAI
deﬁnitions available in the literature,1,3,9 only 1 used
quantiﬁcation of colony forming units, and none required >1
positive culture.3 Therefore, most deﬁnitions may identify
either catheter colonization or contamination during collec-
tion as a VAI.
The NHSN deﬁnition also includes the presence of new cranial
nerve signs, meningeal signs, or headache. Given their underlying
pathology, neurosurgical patients may have these signs and
symptoms, regardless of infection. Other infection surveillance
deﬁnitions relying on clinical signs and symptoms have been
reported to miss cases. A study examining chart-documented
signs and symptoms of catheter-associated urinary tract
infections found that only 9.5% case patients had documented
dysuria, frequency or urgency, and only 4.1% had suprapubic
tenderness or costovertebral angle pain.11 In our cohort, only
9 patients (17.3%) had new or worsening cranial nerve signs, and
none had new or worsening meningeal signs.
A surveillance deﬁnition that cannot adequately discern
VAIs from culture contamination may lead to a mis-
interpretation of clinical practice patterns. In our cohort, only
53.6% of NHSN-deﬁned VAI cases received organism-speciﬁc
antibiotic therapy, and only 5 patients received treatment for
≥14 days. Among “1 colony on 1 piece of media” cases, we





Indication for EVD placementb
Hydrocephalus 43 (87.8)
Intracranial bleeding 42 (85.7)
Intracranial tumor 9 (18.4)
Trauma 3 (6.1)
Where was the EVD placed?
Neuro intensive care unit 28 (57.1)
Operating room 13 (26.5)
Outside hospital 5 (10.2)
Emergency department 3 (6.1)
Neurosurgical history?
≤30 d before EVD placement 8 (16.3)
Surgery while EVD was in place 22 (44.9)
NOTE. EVD, external ventricular drain.
aIncludes 48 patients. One patient had 2 EVDs during study period.
bEVDs may have been placed for ≥1 indication.









Micrococcus spp 6 (11.1)
Corynebacterium spp 4 (7.4)
Propionibacterium spp 3 (5.6)
Streptococcus spp 3 (5.6)
Bacillus spp 2 (3.7)
Arthrobacter spp 1 (1.9)
Gram-negative bacteria
Enterobacter spp 3 (5.6)
Neisseria spp 2 (3.7)
Morraxella spp 1 (1.9)
Klebsiella spp 1 (1.9)
Serratia spp 1 (1.9)
Brenvudimonas spp 1 (1.9)
Fungal
Candida parapsilosis 1 (1.9)
Unidentiﬁed yeast 1 (1.9)
aOf 41 cases, 4 cultures were polymicrobial: 2 cultures had 2 organ-
isms, 1 culture had 4 organisms, and 1 culture had 9 organisms.
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found a signiﬁcantly lower proportion of associated CSF
protein >50mg/dL and CSF glucose <50mg/dL versus other
cases (data not shown). Among the NSHN-deﬁned VAI cases
that grew 1 colony on 1 piece of culture media, only 35%
received organism-speciﬁc antibiotic therapy, and in all these
cases, treatment duration was <9 days. Analogous to central-
line–associated bloodstream infections, EVD removal is
recommended in VAI cases.12 However, among the EVDs in
our cohort with a positive CSF culture, 9 (23.6%) were
removed, and 3 (7.8%) were exchanged. Among VAI cases
with negative CSF cultures, only 2 EVDs (18%) were removed,
and none were exchanged.
Our VAI rate varied considerably, depending on the deﬁnition
applied. For instance, using the Citerio deﬁnition,10 there were no
cases of VAI in 2012; however, using the NHSN deﬁnition, there
were 12 VAI cases, a rate of 10.7 infections per 1,000 EVD days.
When comparing rates among hospitals, this variability becomes
problematic.5 Currently, US hospitals are mandated to report
certain hospital-acquired infections for quality of care metrics,
which are linked to reimbursement.13 Therefore, it is increasingly
important that surveillance deﬁnitions are reproducible and
align well with clinical deﬁnitions. We call for reﬁning the NHSN
VAI deﬁnition and adopting a deﬁnition similar to the current
NHSN central-line–associated bloodstream infection deﬁnition.9
This measure would increase deﬁnition speciﬁcity, and by
removing subjective clinical criteria, would allow for automated
surveillance.14
Our study has several limitations. It was conducted in a
single care center. Also, it was retrospective and relied on pre-
existing documentation. We calculated the Cohen’s κ coefﬁ-
cient for the 3 published deﬁnitions, but we could not directly
compare them to the NHSN deﬁnition because the
ventriculitis cases in all 3 deﬁnitions were a subset of NHSN-
deﬁned VAI cases. The strengths of our study include the
placement of a large number of EVDs in our institution and a
high number of CSF cultures, which allowed the comparison
of various ventriculitis deﬁnitions.
The current NHSN ventriculitis deﬁnition has limitations
that make it difﬁcult to use to compare VAI rates among
institutions and for surveillance. Our data suggest that a
modiﬁcation to the current NHSN deﬁnition is needed to
improve such comparisons in the future.
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